MDMA surveys members on GPOs
This article was originally published in The Gray Sheet
Medical Device Manufacturers Association solicits comments from over 160 member companies on group purchasing operations, including successes, failures, problems that persist or are resolved since April 2002 Senate Judiciary/Antitrust Subcommittee hearing. Comments will be collected via 1MDMA's website. A follow-up hearing is scheduled for late July...
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.